Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Number of holders
-
34
-
Total principal
-
320M
-
Principal change
-
-3.65M
-
Total reported value, excl. options
-
$282M
-
Value change
-
-$9.9M
-
Number of buys
-
13
-
Number of sells
-
-14
-
Price
-
$0.99
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q2 2022
34 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q2 2022.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 34 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $320M of principal
.
Largest 10 bondholders include Allianz Asset Management GmbH ($118M of principal), MACKAY SHIELDS LLC ($76.9M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($37.5M of principal), Thrivent Financial for Lutherans ($14.9M of principal), STATE STREET CORP ($13M of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($12M of principal), Sonora Investment Management Group, LLC ($8.3M of principal), BlackRock Inc. ($6.7M of principal), NEW YORK STATE COMMON RETIREMENT FUND ($6.3M of principal), and Invesco Ltd. ($6M of principal).
This table shows the top 34 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.